Protagonist Therapeutics: Transforming Healthcare With top-Quality Peptide Drugs
Reading Time: 3 minutes
Protagonist Therapeutics is a biopharmaceutical company in the clinical stage focused on the discovery and development of peptide-based therapeutics. The company utilizes a proprietary technology platform to develop novel oral and injectable peptides targeting protein-protein interactions. Shares surged on March 10, 2025, after the company's drug partnered with Johnson & Johnson outperformed its competitor from Bristol Myers Squibb in a study involving patients with plaque psoriasis. Protagonist Therapeutics (NASDAQ: PTGX) is a...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
